Patent · US Expired

Time-staggered utilization of tumor cells in combination with intact antibodies for immunization

US6994853B1 · kind B1 · utility

80Cited by

5References

39Claims

0Family size

Assignee

Trion Pharma GmbH · DE

Inventors

Horst Lindhofer · Puchheim, DE
Peter Ruf · Binningen, CH

Key dates

Filing date	Sep 22, 1999
Grant date	Feb 7, 2006
Priority date	—
Expiry date	Sep 22, 2019

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the time-staggered utilization of tumor cells in combination with intact, preferably heterologous antibodies for the immunization of humans and animals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.